Correlating Urinary Tract Infection Risks With Sodium-Glucose Cotransporter-2 Inhibitors: Insights From the National Health Insurance Data of Korea. [PDF]
Jeon BJ, Ko YJ, Park JY, Bae JH, Tae BS.
europepmc +1 more source
Neuroprotective Potential of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Type 2 Diabetes: A Narrative Review. [PDF]
R R, Buttar AS.
europepmc +1 more source
SGLT-2 Inhibitors and GLP-1 Receptor Agonists as Combination Therapy in Type 2 Diabetes. [PDF]
Liakos A +3 more
europepmc +1 more source
Sodium-glucose cotransporter 2 inhibitor in heart failure patients and their outcomes: A meta-analysis of randomized controlled trials. [PDF]
Parsi S +4 more
europepmc +1 more source
Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study. [PDF]
Ternhamar T +3 more
europepmc +1 more source
Sodium-Glucose Cotransporter 2 Inhibitor Use in Adults Undergoing Peritoneal Dialysis: A Propensity-Matched Real-World Data Analysis. [PDF]
Amelunxen E +7 more
europepmc +1 more source

